Hypercoagulability Completed Phase 3 Trials for Dalteparin (DB06779)

Also known as: Thrombophilia / Hypercoagulation / Protein C Deficiency / Antithrombin III deficiency

IndicationStatusPhase
DBCOND0035276 (Hypercoagulability)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00967382TIPPS: Thrombophilia in Pregnancy Prophylaxis StudyTreatment